Veritas In Silico Inc. (TYO:130A)

Japan flag Japan · Delayed Price · Currency is JPY
644.00
+3.00 (0.47%)
Last updated: Jul 25, 2025
0.47%
Market Cap5.06B
Revenue (ttm)186.60M
Net Income (ttm)-228.62M
Shares Out6.49M
EPS (ttm)-35.24
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume556,125
Open641.00
Previous Close641.00
Day's Range641.00 - 644.00
52-Week Range563.00 - 1,348.00
Betan/a
RSI59.97
Earnings DateAug 4, 2025

About United States Steel

Veritas In Silico Inc. engages in the business of small molecule drug discovery and nucleic acid drug discovery targeting mRNA. It has strategic partnership with Liverpool ChiroChem for the mRNA-targeted drug discovery and development. The company was incorporated in 2016 and is based in Shinagawa, Japan. [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 2016
Country Japan
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 130A
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.